Skip to content

Clinical trials

Recruiting Phase 3 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Status: Recruiting Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20161
20183
20192
20202
20211
20225
202313
20249
202514
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Canadian Cancer Trials Group3
The First Affiliated Hospital with Nanjing Medical University3
Alliance for Clinical Trials in Oncology2
Memorial Sloan Kettering Cancer Center2
Merck Sharp & Dohme LLC2
Norroy Bioscience Co., LTD2
SWOG Cancer Research Network2
Telix Pharmaceuticals (Innovations) Pty Limited2
ABX advanced biochemical compounds GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms66
Neoplasm Metastasis2
Urogenital Neoplasms2
Adenocarcinoma1
Breast Neoplasms1
Bulbo-Spinal Atrophy, X-Linked1
Carcinoma, Renal Cell1
Colonic Neoplasms1
Disease1
Erectile Dysfunction1

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.